May 9 |
Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2024 Financial Results
|
May 9 |
Sangamo Therapeutics Presents Next-Generation Modular Integrase Technology Engineered to Enable Large-Scale Genome Editing
|
May 8 |
Sangamo Therapeutics Q1 2024 Earnings Preview
|
May 2 |
Cardiff Oncology (CRDF) Reports Q1 Loss, Tops Revenue Estimates
|
May 2 |
Sangamo Therapeutics Announces First Quarter 2024 Conference Call and Webcast
|
Apr 22 |
Sangamo Therapeutics to Present Neurology-Focused Pre-Clinical Data From Its Epigenetic Regulation, Capsid Delivery and Genome Engineering Platforms at the 27th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
|